PE/Cyanine5.5 Anti-Mouse CD45R/B220 Antibody[RA3.3A 1/6.1]

Introducing the PE/Cyanine5.5 Anti-Mouse CD45R/B220 Antibody [RA3.3A 1/6.1], a highly specialized and meticulously crafted product designed to cater to the discerning needs of scientific research and experimentation. This antibody, meticulously developed using cutting-edge technology, offers an unparalleled level of specificity and accuracy in detecting and analyzing the CD45R/B220 antigen in mouse samples.

The PE/Cyanine5.5 conjugation ensures optimal fluorescence emission, enabling precise and reliable identification of CD45R/B220-positive cells. With its exceptional sensitivity and low background noise, this antibody guarantees accurate and reproducible results, empowering researchers to delve deeper into the intricacies of mouse immune system dynamics.

Crafted with utmost precision, the PE/Cyanine5.5 Anti-Mouse CD45R/B220 Antibody [RA3.3A 1/6.1] exhibits exceptional batch-to-batch consistency, ensuring reliable and reproducible outcomes across experiments. Its high affinity and specificity for the CD45R/B220 antigen make it an indispensable tool for immunophenotyping studies, facilitating the identification and characterization of B cells and subsets thereof.

This antibody, meticulously validated through rigorous quality control measures, guarantees optimal performance and reliability, instilling confidence in researchers seeking to unravel the complexities of mouse immune responses. Its compatibility with various experimental techniques, including flow cytometry and immunofluorescence, further enhances its versatility and utility in diverse research applications.

In summary, the PE/Cyanine5.5 Anti-Mouse CD45R/B220 Antibody [RA3.3A 1/6.1] stands as a pinnacle of scientific excellence, offering researchers an invaluable tool to unravel the mysteries of mouse immune system dynamics. With its exceptional specificity, sensitivity, and reliability, this antibody is poised to revolutionize immunophenotyping studies, empowering scientists to make groundbreaking discoveries in the realm of immunology.